Cardinal Health Inc vs GraniteShares 2x Long NVDA Daily ETF — how do they compare? Cardinal Health Inc trades at $229 (market cap $53.89B), while GraniteShares 2x Long NVDA Daily ETF trades at $33.53. The key difference: Cardinal Health Inc pays a 0.89% dividend while GraniteShares 2x Long NVDA Daily ETF pays none, and Cardinal Health Inc is trading nearer its 52-week high, GraniteShares 2x Long NVDA Daily ETF nearer its low. Which is the better fit depends on your goals.
| CAH | NVDL | |
|---|---|---|
Market Cap | $53.89B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $239.71 | $43.02 |
52-Week Low | $146.04 | $21.76 |
Enterprise Value | $58.87B | — |
Dividend Yield | 0.89% | — |
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
NVDL, the GraniteShares 2x Long NVDA Daily ETF, trades at $30.7, down 7.05% in the last 24 hours, reflecting high volatility tied to its leveraged exposure to NVIDIA. Technical indicators show a bullish trend with moving averages supporting upward momentum, while oscillators remain neutral. Recent stock splits on June 25 and 26, 2026, adjusted the share structure, but key financial ratios like P/E and P/S are unavailable, limiting fundamental clarity. The ETF's performance is directly driven by daily NVIDIA price movements, amplified by its 2x leverage.
The outlook for NVDL hinges on NVIDIA's AI-driven growth, offering potential for high returns but with significant risk due to leverage compounding losses during downturns. Investors face volatility risks, as seen in a 12% single-day drop on June 5, 2026, and must monitor NVIDIA's earnings and broader semiconductor trends. Caution is advised given the lack of traditional fundamentals and the ETF's reset mechanism, which can erode value over time in volatile markets.
Trailing returns across standard periods
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →NVDL is a leveraged ETF that seeks daily investment results corresponding to 200% (2x) of the daily performance of NVIDIA Corporation (NVDA) stock. It is designed as a tactical trading tool for investors with a strong bullish (long) view on NVDA. Due to the effects of compounding and leverage, the ETF is intended to be held for a single day and is not suitable for long-term investment, as its performance over longer periods may significantly deviate from two times the performance of the NVDA stock.
Read more on NVDL →